The Cooper Companies Inc (BSP:C1OO34)
R$ 60.54 0 (0%) Market Cap: 120.57 Bil Enterprise Value: 135.18 Bil PE Ratio: 58.61 PB Ratio: 2.64 GF Score: 81/100

Cooper Companies Inc at Raymond James Life Sciences & MedTech Conference Transcript

Jun 18, 2019 / 02:20PM GMT
Lawrence Soren Keusch
Raymond James & Associates, Inc., Research Division - MD

Okay. Welcome, everyone, to our next presentation here. I'm Larry Keusch, the hospital supply analyst. Thank you again for attending the inaugural Raymond James Life Sciences & MedTech Conference. We're extremely honored to have Al White, who is the President and Chief Executive Officer of Cooper, join us. He flew across the country for this meeting. So we really do appreciate it. We also have Kim Duncan, who's the Vice President, Investor Relations as well with us.

So Al, there's obviously a lot to cover. It's exciting times at Cooper right now. You guys are -- you've got growth drivers all over the place. But maybe just -- I want to just start at a very high level and maybe just think a little bit about the market itself. It's historically been a very consistent 4% to 6% grower. I think even in 2009, I mean, we really didn't get below 3% growth. So it's a consistent growth driver.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot